Skip to content


Call for papers: Cancer Immunotherapy and Vaccines

Guest Editor: Professor Francesco Pappalardo

BMC Immunology is currently accepting manuscripts to the new thematic series “Cancer Immunotherapy and Vaccines”.

New Content Item © PixabayThe purpose of this thematic series is to bring together the latest advances in both biological and computational research, looking broadly at the basic biological aspects of immunotherapy, emerging immunotherapies (both prophylactic and preventive) and different vaccination approaches.

This includes, but is not limited to, tumour immunology, immunological control mechanisms and the role of other aspects of the immune system (such as antibody responses and the innate immune system) and also computer modelling and machine learning for cancer immunotherapy and vaccination approaches, including in silico clinical  approaches.  We also welcome manuscripts that illustrate how biological and computational approaches can complement each other in developing new immunotherapies.

Please submit directly to BMC Immunology stating in your cover letter that it is for the “Cancer Immunotherapy and Vaccines” collection. Alternatively you can email your pre-submission queries to the Editor of BMC Immunology at

The deadline for submission of manuscripts is November 30th, 2017.

  1. Content type: Research article

    CIGB-247, a VSSP-adjuvanted VEGF-based vaccine, was evaluated in a phase I clinical trial in patients with advanced solid tumors (CENTAURO). Vaccination with the maximum dose of antigen showed an excellent saf...

    Authors: Javier Sánchez Ramírez, Yanelys Morera Díaz, Mónica Bequet-Romero, Francisco Hernández-Bernal, Katty-Hind Selman-Housein Bernal, Ana de la Torre Santos, Eduardo Rafael Santiesteban Álvarez, Yenima Martín Bauta, Cimara H. Bermúdez Badell, Josué de la Torre Pupo, Jorge V. Gavilondo and Marta Ayala Avila

    Citation: BMC Immunology 2017 18:39

    Published on: